Leading in-house counsel to address patent forum

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Leading in-house counsel to address patent forum

In-house counsel from Audi, GE Healthcare, GSK, Nokia, Philips, Skype, UBS and Unilever are speaking at Managing IP’s second International Patent Forum, taking place in London on April 18 and 19

Richard Vary of Nokia will take part in panels on European patent reform and forum shopping in Europe, while Matthew Goodwin of Unilever and Maaike van Velzen of Philips will both feature on a panel on managing your international portfolio.

Sonia Cooper of Skype will speak on high-tech, electronics and software patents while David Rosenberg of GSK will take part in a panel on life sciences.

Kai Brandt of Audi will take part in a session on China, Catriona Hammer of GE Healthcare will speak on notable changes and desirable advances in the patent system and Stefano Nappo of UBS will speak on risk management strategies.

The forum takes place in London on April 18 and 19. Attendance is free for in-house patent/IP counsel, academics and R&D professionals who register in advance. Registration and further information is available online.

It will also feature keynote speeches from EPO President Benoît Battistelli, USPTO Director David Kappos and WIPO Deputy Director-General Jim Pooley.

More speakers are due to be confirmed in the next few days.

A special session featuring representatives of WIPO, EPO, JPO and USPTO will look at public perceptions of patents and IP rights in the context of recent controversies over developments such as ACTA, SOPA and PIPA.

About 250 people are expected to attend the forum. Companies already registered include Alcatel-Lucent, Audi, BSkyB, BT, Cambridge Display Technology, Cipla, ConocoPhilips, DSM, e2v, Enterprise Ireland, Ericsson, France Telecom Orange, GE Healthcare, GlaxoSmithKline, Huntsman Advanced Materials, Husqvarna AB, Intelligent Energy, Isis Innovation, Jaguar Land Rover, Kraft, MSD, National Institute of Immunology, NEC, Nestec, Nokia, Oclaro, Oxis Energy, Philips, Richemont International, Siemens, Skype, Smartmatic, Sony, The Telecommunication Planning Research Institute of MIIT China, UBS, Unilever, and Zydus Cadila.



more from across site and SHARED ros bottom lb

More from across our site

François Pochart, Grégoire Desrousseaux and Lionel Martin, long-standing figures in the firm’s patent litigation team, are set to help launch a Paris-based litigation offering
The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
IP experts gathered in San Francisco last week to discuss the changing global SEP landscape and new licensing models for AI infrastructure
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
The government is targeting earlier resolution of SEP disputes while ruling out a standalone IPEC rate determination track and restrictions on injunctions
Gift this article